Qingping Dou

Dr. Qingping Dou serves as Professor of Oncology and Pharmacology at Wayne State University School of Medicine, with offices at 4100 John R. Street, Detroit. His laboratory focuses on discovering molecular targets for cancer therapy.

Research expertise includes targeted cancer therapies, drug discovery, natural products, and chemoprevention. Key discoveries include pioneering work on proteasome inhibitors that selectively induce apoptosis in cancer cells and investigations into tea polyphenols, curcumin analogs, and novel metal complexes that inhibit proteasome activity.

Current research examines the BCA2-AMPK regulatory pathway in breast cancer and its implications for improving metformin-based therapies. Laboratory findings have contributed to understanding how natural compounds enhance the efficacy of existing cancer treatments.